, the avian influenza A(H7N9) virus [A(H7N9)] human infections appeared in Eastern China starting in February 2013 [3] [4] [5] [6] [7] . A total of 133 human A(H7N9) virus infection with a case-fatality rate of 32% were reported within 3 months after the announcement of the first case on 31 March 2013 [8] . We reported the first patient, whose A(H7N9) virus isolate has a genome closely matched phylogenetically with that of a chicken A(H7N9) virus isolated from an epidemiologically linked live poultry market [3] . Unlike previous H7 subtype virus infections, which usually caused upper respiratory tract symptoms and acute conjunctivitis [9] , patients with A(H7N9) virus infection generally presented with acute community-acquired pneumonia with radiological evidence of bilateral consolidations and ground glass changes not responding to typical and atypical antibacterial coverage [3, 10] . The disease rapidly progressed with acute respiratory distress syndrome (ARDS) and multiorgan dysfunction. Asymptomatic or mild upper respiratory tract infections appear to be rare [11] . The histopathological changes of the A(H5N1) virus were previously reported but not A(H7N9) virus infection. Little is known about the organs and tissues affected by this emerging virus and their correlation with the clinical manifestations and disease progression. We analyzed the findings from the serial clinical, virological, and laboratory studies and correlated them with the histopathological features of their postmortem tissue biopsy.
PATIENTS AND METHODS
This study was approved by the Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University (reference number 2013-157). All patients with laboratoryconfirmed A(H7N9) infection admitted to the intensive care unit of Zhejiang University First Affiliated Hospital during 10-23 April 2013 were included. Data of these patients were embedded within a cohort of 111 patients in a previous report on the clinical and epidemiological features of A(H7N9) infection [10] , but not included in our previous publication [3] . Here we report the detailed and serial clinical findings including history and physical examination, hematological, biochemical, radiological, and virological investigation results, which were entered into a predesigned database. Their APACHE II (Acute Physiology and Chronic Health Evaluation II) scores were determined [12] . ARDS and disseminated intravascular coagulation (DIC) were determined with standard criteria [10, 14] .
All patients had the diagnosis of A(H7N9) virus infection confirmed by reverse transcription polymerase chain reaction (RT-PCR) testing targeting the M, H7, and N9 genes in their clinical specimens as described previously [3, 15] . Serial sampling of their respiratory secretions, blood, urine, and stool was performed. The viral load of all positive samples was determined by TaqMan real-time RT-PCR with standard thermocycling conditions for the H7 gene as described previously [3] . The primers and probe for quantitation were as follows: H7-forward (AGA GTCATTRCARAATAGAATACAGAT), H7-reverse (CACYGC ATGTTTCCATTCTT), and H7-probe (FAM-AAACATGATGC CCCGAAGCTAAAC-BHQ1). Viral load was inferred from the cycle threshold (Ct) value of the RT-PCR.
We investigated urine samples and blood, sputum, or endotracheal aspirates bacteriologically, as clinically indicated. Antibiotic susceptibility was determined using Clinical and Laboratory Standards Institute criteria [16] . Multidrug-resistant Acinetobacter baumannii was defined as resistant to all aminoglycoside, penicillins, carbapanems, cephalosporins, and fluo-roquinolones [17] . Hemagglutination inhibition (HAI) assay was determined as described previously [18] . An HAI titer of ≥40 was defined as seropositive.
The histopathological features were reported for 3 patients whose relatives consented to limited postmortem biopsy. Full autopsies of these patients could not be obtained due to religious and other reasons. All cadavers were stored at 4°C. Trucut postmortem biopsies within 18-20 hours after death were obtained from the right and left lung at the sixth intercostal space posteriorly, the heart at the left sternal border anteriorly, the liver at the right midaxillary line and the ninth intercostal space, the kidneys at the costovertebral angle posteriorly, and the spleen at the left posterior-axillary line and the 10th intercostal space. Two successful biopsies for each organ were performed aseptically according to standard guidelines with one put into 4% formalin for histopathological examination and the other into viral transport medium for viral load study. The paramortem lumbar puncture was performed and bone marrow biopsy was taken at the posterior superior iliac spine and put into ethylenediaminetetraacetic acid bottles. Histopathological changes were examined on hematoxylin-and-eosin-stained tissue sections under light microscopy. Immunohistochemical staining was performed using anti-influenza A nucleoprotein monoclonal antibody as we described previously [19] [20] [21] . In brief, formalin-fixed, paraffin-embedded sections were incubated with the monoclonal antibody at 1:5000 dilution at 4°C overnight, then incubated with goat antimouse immunoglobulin G and heavy chain-specific and light chain-specific biotin conjugate (Calbiochem) at 1:2000 dilution for 30 minutes at room temperature. After incubation with streptavidin/peroxidase complex reagent (Vector Laboratories) for 30 minutes at room temperature, color was developed using 3, 3′-diaminobenzidine (Vector Laboratories) according to the manufacturer's instructions [22] .
All statistical analyses were performed using PASW Statistics software, version 18.0.0 for Windows. The APACHE scores and the median Ct value of RT-PCR were compared using MannWhitney U test. For statistical comparison of the Ct values, a Ct value of 40 was arbitrarily assigned to patients below the detection limit of the assay. P values <.05 were considered to represent statistically significant differences.
RESULTS
At the time of writing, there was a total of 40 hospitalized patients with 8 fatalities. This study included 6 patients who died ( patients 1-6) and 6 survivors ( patients 7-12) admitted to our intensive care unit between 10 April and 23 April 2013. All 6 fatal cases and 5 survivors were transferred from other hospitals, whereas 1 survivor was admitted directly to our hospital. During hospitalization, all fatal cases developed ARDS (Supplementary Table 1 ). Five patients (83%) developed acute renal impairment, and 4 (67%) patients had heart failure and shock. Three (50%) developed hepatic dysfunction. DIC was present in 4 patients (67%), and 5 (83%) had lymphopenia. Three patients (50%) had elevated creatine kinase levels. All received oseltamivir at 5-7 days after symptom onset. All received antibiotics and intravenous immunoglobulin, and 4 patients (67%) received extracorporeal membrane oxygenation (ECMO). One patient (patient 1) died 8 days after symptom onset, 2 patients (patients 2 and 3) died 11 days after symptom onset, and 3 (patients 4-6) died >3 weeks after symptom onset. The survival group consists of 3 male and 3 female patients, with a median age of 57.5 years (range, 37-65 years; Supplementary Table 2) . Two survivors required invasive positive pressure ventilation and ECMO. The median APACHE II score was higher for the fatal cases than the survivors (32 vs 16, P = .004).
Nosocomial infection developed in 5 fatal cases and 3 survivors. Bacteremia occurred in 4 fatal cases (67%) and 2 survivors (33%) ( Table 1 ). For the fatal cases, blood culture yielded Klebsiella pneumoniae in patients 4, 5, and 6, A. baumannii in patient 5, and coagulase-negative Staphylococcus in patient 3. Among the survivors, K. pneumoniae was isolated from blood culture of patient 9, and coagulase-negative Staphylococcus was isolated from patient 7. Sputum culture grew bacterial pathogens in 5 fatal cases (83%) and 2 survivors (33%). For fatal cases, K. pneumoniae was found in patient 4 and patient 6, whereas A. baumannii was found in patients 2, 3, and 5. For the survivors, Burkholderia cepacia was isolated from patients 8 and 9, and A. baumannii and K. pneumoniae were found in patient 8. Pleural fluid from patient 6 also grew K. pneumoniae. All A. baumannii isolates from these patients were multidrugresistant, whereas all K. pneumoniae isolates were resistant to carbapenems. For patient 1, blood culture was negative, and sputum culture only grew commensals. Urine culture was negative for bacterial growth in all 6 patients.
RT-PCR after admission to our intensive care unit showed that viral nucleic acid is still detectable in the nasopharyngeal swab for 83% (5/6) of the fatal cases and 67% (4/6) of the survivors (Table 2) . Among individual patients with virus still detectable in either the nasopharyngeal swab or sputum by RT-PCR, the Ct value was lower in the sputum sample in than the nasopharyngeal swab for all fatal cases (5/5) but higher or equal in 3 of the 5 survivors. The median Ct value was significantly lower in the nasopharyngeal swabs than the sputum samples for the fatal cases (23 vs 32, P = .042), but this was not significant for the survivors (30.5 vs 34, P = .144). The median Ct value for sputum was lower for the fatal cases than the survivors, almost reaching statistical significance (23 vs 30.5, P = .08). RT-PCR positivity in nasopharyngeal swabs ranged from 7 to 11 days after symptom onset for fatal cases and from 7 to 9 days for survivors, Prolonged viral shedding in sputum specimens for ≥10 days occurred in 3 fatal cases (50%) and 3 survivors (50%), with a maximum duration of up to day 15 after symptom onset in patient 4.
RT-PCR was positive in stool specimens of 4 patients (67%). For patient 5, RT-PCR was still positive in the stool specimen 10 days after symptom onset when the nasopharyngeal swab and sputum specimens were already negative. In comparison, 2 of 6 survivors (33%) had positive RT-PCR in the stool. None of the patients had positive RT-PCR in the urine or blood (Supplementary Table 3 ). All paramortem tissue samples, including lung, heart, liver, kidney, spleen, and bone marrow tissue, were negative by RT-PCR and viral culture. The cerebrospinal fluid specimens of patients 1, 2, and 3 were negative by RT-PCR and viral culture.
For serum samples collected within 7 days of symptom onset, none of the fatal cases had an HAI titer of 40, but 1 survivor had a titer of 40 (Table 3) . For serum samples collected between day 8 to day 10 after symptom onset, 33% (2/6) of the fatal cases and 83% (5/6) of the survivors had serum HAI titers ≥40. Among the 10 patients with serum samples available >10 days a No bacterial copathogens were isolated from patients 1, 10, 11, and 12.
b Refers to the first day the bacteria were isolated.
c Klebsiella pneumoniae was isolated from pleural fluid on day 22 after symptom onset and day 20 after hospitalization.
after symptom onset (4 fatal cases and 6 survivors), a ≥4-fold increase in the HAI titer was observed in all patients. The highest HAI titer from the fatal cases was 320, whereas the highest HAI titer from survivors was 1280.
Paramortem examination was performed for 3 patients (Table 4) . In all 3 patients, predominant polymorphonuclear cell infiltration of alveoli was observed in the lungs. Patient 1, who died 8 days after symptom onset, had diffuse alveolar damage with proteinaceous exudate, occasional cytomegaly, and intra-alveolar hemorrhage, but no evidence of fibroproliferative changes in the lung ( Figure 1A and 1B) . In contrast, patients 2 and 3, who died 11 days after symptom onset, had pulmonary fibroproliferative changes ( Figure 1C ). Immunohistochemical staining for influenza A virus nucleoprotein using specific antinucleoprotein antibody showed viral antigen expression in the alveolar epithelium ( Figure 1D ). Extrapulmonary histopathological features included reactive hemophagocytosis in the bone marrow and lymphoid atrophy in the splenic tissue for patients 1 and 2 ( Figure 2A and 2B) , whereas renal tubular degeneration was present in patients 2 and 3 ( Figure 2C ). The liver of patient 1 showed spotty hepatic necrosis, whereas the liver of patient 3 showed microvesicular and macrovesicular steatosis ( Figure 2D ). Patient 2, who had lymphoma with an abnormally high peripheral blood lymphocyte count, also showed CD20-positive atypical lymphocytes in the spleen.
DISCUSSION
The A(H7N9) virus has become the most prevalent avian-origin influenza virus subtype affecting humans in China within 2 months after its discovery, almost tripling the total number of human A(H5N1) virus infections in China within the last 10 years [23] . It is also one of the most virulent respiratory tract viruses infecting humans [23] . We and others have previously reported the clinical, virological, and epidemiological features of the human cases [3, 10, 11, 24] . In this study, we described 6 fatal human cases in detail, and compared them with 6 survivors. This is also the first study to report on the histopathological changes in fatal cases. Previous studies on human seasonal, pandemic, and avian influenza showed that the histopathological damages could be divided into 3 stages [15, 22, 25] . An exudative inflammatory phase is seen in patients who died within 10 days after symptom onset, characterized by edema, fibrous exudates, and hyaline membranes. Those who survived would develop the fibroproliferative phase with organizing diffuse alveolar damage and later interstitial fibrosis. In this study, patient 1, who died on day 8 after symptom onset, had intra-alveolar hemorrhage, diffuse alveolar damage, and hyaline formation without fibroproliferative changes. The features are compatible with the acute exudative inflammatory phasewhen immunostaining for influenza Avirus nucleoprotein expression is positive in the alveolar epithelium. In contrast, patients 2 and 3, who died on day 11 after symptom onset, developed pneumocyte hyperplasia and interstitial fibrosis in addition to the diffuse alveolar damage, which were compatible with the fibroproliferative phase.
Numerous extrapulmonary histopathological manifestations were previously described in patients with A(H5N1) virus infection. Reactive hemophagocytosis, which was identified in patients 1 and 2, is also a complication in patients with A (H5N1) virus infection [1, 25, 26] . Renal tubular degeneration found in patients 2 and 3 correlated with the elevated blood creatinine levels. Extensive renal tubular necrosis in the kidney was also found in patients with A(H5N1) virus infection [26] . Previous studies have shown the presence of α2,3-sialic acid in glomeruli and renal tubule with detectable viral RNA [27] . Patient 3, who had the highest levels of liver parenchymal enzymes, had hepatic steatosis. Similar changes were found in an A(H5N1)-infected child with Reye syndrome [28] .
To assess the roles of virological damage and host response in the pathogenesis of these histopathological and clinical features of A(H7N9) virus infection, we studied the patients' serial viral loads on pulmonary and extrapulmonary specimens. The viral load was higher and the duration of shedding was longer in sputum specimens than nasopharyngeal swabs, suggesting that lower respiratory tract specimens would be the preferred specimen for diagnosis for severe cases. This is compatible with the predilection of the A(H7N9) virus for the lower respiratory tract as in A(H5N1) virus infection. Moreover the viral load appears to be higher within the first 10 days after symptom onset during the acute exudative phase. Therefore, the initiation of neuraminidase inhibitor beyond 48 hours after symptom onset may still change the prognosis of these patients. However, we cannot ascertain whether any reduction in viral load was related to oseltamivir or the natural course of infection as most patients received oseltamivir treatment during serial sampling. Furthermore, prolonged viral shedding can occur; this happened up to 16 days after symptom onset in this cohort but can be up to 20 days, as shown in our previous case [3] .
Among the extrapulmonary specimens, RT-PCR for A(H7N9) virus was positive in the stool of 67% of our patients who died, which is a compatible with a recent series showing a positive rate of 86% in patients with severe A(H7N9) virus infection [24] . This rate is much higher than those found in other human or avian influenza, at <5% for A(H1N1)pdm09 and 33% in a study of A(H5N1) virus infection [29] [30] [31] . In A(H5N1) virus infection, influenza antigen can be detected in the small intestine [26] . Notably, patient 5 had an RT-PCR-positive stool sample on as late as day 10 after symptom onset when RT-PCR on the respiratory tract samples were already negative. Only 1 of the 4 patients ( patient 4) with stool positive by RT-PCR had diarrhea. This has important implication on the infection control strategies of A(H7N9) virus infection. As the influenza virus in stool may contaminate the surrounding environment, patients with A(H7N9) virus infection should also be placed under contact precaution in addition to droplet precaution, irrespective of the presence or absence of diarrhea. We did not detect viral RNA in the blood and urine of any of the patients. This is in contrast to a previous study, which showed that all their patients with A(H7N9) had either viremia or viruria [24] . In a previous study of A(H5N1) virus infection, viremia was detected in 82% of the fatal cases, but absent in nonfatal cases [32] . Our findings suggest that extrapulmonary detection in form of viremia is uncommon for A(H7N9) virus infection, which is compatible with a lower mortality rate for A(H7N9) virus than that of A(H5N1) virus infection.
A >4-fold increase of HAI titer between the acute and convalescent serum sample was observed in all 10 patients with serum samples collected >10 days apart, suggesting that HAI titer is still a reliable method for the diagnosis of A(H7N9) virus infection. This is in contrast to A(H5N1) virus infection, in which microneutralization assay was found to be more sensitive than HAI assay [33] . However, further studies with a larger cohort are required to verify this finding.
There are several limitations to our study. First, only limited paramortem examination was performed due to cultural and religious reasons. Other organs that may be affected, including the gastrointestinal tract, could not be examined in detail. Second, paramortem examination was not performed in the 3 patients who died 3 weeks after symptom onset, as their relatives did not consent to the procedure. Therefore, the information on the histopathological findings in patients who died late is limited. Further studies on these patients are necessary to enhance our understanding on the late effects of A(H7N9) virus infections in humans. Finally, as some patients were transferred to our hospital after the diagnosis was confirmed by RT-PCR, the initial sample for some patients were not available for more detailed analysis.
In summary, avian influenza A(H7N9) virus infection has many similarities to A(H5N1) virus infection in terms of poultry contact, relative paucity of upper respiratory tract symptoms, rapidly progressive pneumonia leading to ARDS and multiorgan dysfunction, a higher viral load in the lower than upper respiratory tract, and reactive hemophagocytosis with cytopenia. Patients with A(H7N9) virus infection tend to be older with major underlying medical illness, and extrapulmonary viral replication was not evident in our cohort except for the detection of the virus in stool, which may have implications in infection control. Early initiation of treatment by neuraminidase inhibitor may be important as all our fatal cases received oseltamivir treatment ≥5 days after symptom onset [34] . The frequent isolation of K. pneumoniae and A. baumannii from blood and sputum cultures of fatal cases suggest that bacterial superinfection can be a significant problem in these patients, who may have been colonized from prior healthcare exposure. Infection control measures with auditing on hand hygiene, enteral feeding with raised bed head, maintaining the close systems of ventilator tubings, and cohorting of patients with multidrug-resistant gram-negative bacilli are now instituted in our intensive care unit.
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